Telemetric Arrhythmia and Syncope Diagnosis - Evaluation of Arrhythmia Treatment Efficacy
NCT ID: NCT01265303
Last Updated: 2013-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
360 participants
INTERVENTIONAL
2011-02-28
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimizing Diagnostics Of Syncope Events Using Intelligent Telemetric Solutions.
NCT01265290
Telemetric Arrhythmia Diagnosis in Adults
NCT01265758
Optimizing Diagnostics Of Arrhythmia Events In Children Using Intelligent Telemetric Solutions
NCT01265771
Diagnosis of Arrhythmias in Syncope by Pocket-ECG III® or Conventional Holter
NCT02614235
Non-invasive Differentiation of Supraventricular Tachyarrhythmia
NCT06061120
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients with no record of arrhythmia requiring treatment during the first 14 days ECG monitoring will terminate participation in the study. The referring physician will be informed. Further diagnosis or treatment should be performed at the referring physician's center according to the best clinical practice.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Catheter ablation
Prolonged telemetric Full Disclosure ECG recording.
Continuous Full Disclosure Telemetric ECG monitoring lasting 14 days
Pacemaker implantation
Prolonged telemetric Full Disclosure ECG recording.
Continuous Full Disclosure Telemetric ECG monitoring lasting 14 days
Pharmacotherapy
Prolonged telemetric Full Disclosure ECG recording.
Continuous Full Disclosure Telemetric ECG monitoring lasting 14 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prolonged telemetric Full Disclosure ECG recording.
Continuous Full Disclosure Telemetric ECG monitoring lasting 14 days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Physician recommendation for ablation treatment of arrhythmia
* Patient informed consent
* Declarative and feasible compliance (patient understands basic instructions regarding device use)
Exclusion Criteria
* Lack of patient cooperation
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Cardiology, Warsaw, Poland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Institute of Cardiology, Warsaw Poland
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lukasz J Szumowski, MD, PhD
Role: STUDY_CHAIR
National Institute of Cardiology, Warsaw, Poland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitair Ziekenhuis Brussel Centre for Heart- and Vascular diseases
Brussels, , Belgium
Klinika Kardiologii CMKP
Warsaw, , Poland
Institute of Cardiology
Warsaw, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UDAPOIG.01.03.01-00-068/09-00D
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.